Comparison of neutrophil to lymphocyte ratio and plateletto lymphocyte ratio in patients diagnosed with trigeminalneuralgia and healthy controls

Aim: Trigeminal neuralgia (TN) is a common cranial nerve disease, but its pathogenesis has not yet been fully elucidated. Theneutrophil-lymphocyte ratio (NLR) and the platelet-lymphocyte ratio (PLR) have been investigated in recent years as markers ofsystemic inflammation, and their determination presents as a lower-cost, more practical, and simpler method compared to otherinflammation markers. This study aimed to evaluate the possible role of systemic inflammation in TN etiopathogenesis based onNLR and PLR values. Materials and Methods: The study included 55 male and female patients aged 18 to 60 years, who were diagnosed with TN at theNeurology Clinic of our university according to the criteria of Headache Classification Committee of the International HeadacheSociety 2018 (Cephalalgia2018), and 48 healthy controls. Demographic and clinical variables, such as age and gender wereretrospectively obtained from medical records. Results: In terms of sociodemographic data, both groups had similar characteristics. The NLR values were 1.84±0.81 for the patientgroup and 1.92±0.79 for the control group. There was no statistically significant difference in NLR between the two groups (p =0.447). The PLR values were 101.91±30.24 and 97.84±30.24 for the patient and control groups, respectively, indicating no statisticallysignificant difference (p = 0.439).Conclusions: The role of systemic inflammation in TN pathophysiology remains controversial. It is considered that an inflammatoryprocess may occur in the pathophysiology of TN, but this is characterized by local neurogenic inflammation rather than the effectof a systemic inflammatory response.

PDF

___

1. Love S, Coakham HB. Trigeminal neuralgia: Pathology and pathogenesis, Brain 2001;124:2347-60.
2. Yao Y, Chang B, Li S. Relationship of Inflammation with Trigeminal Neuralgia. J Cranio fac Surg 2020;31:110- 3.
3. Celebisoy M. Trigeminal nevre disases. J Int Med Sci 2006;2:23-34.
4. Mason WE, Kollros P, Jannetta P. Trigeminal Neuralgia and ItsTreatment in a 13-Month-OId Child. J Craniomandibular disodr. facial oral pain 1991;5:213- 6 .
5. Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ 2007;334:201-5.
6. Cruccu G, Finnerup NB, Jensen TS, et al.Trigeminal neuralgia: new classification and diagnostic grading for practice and research. Neurology 2016;87:1-9.
7. Godazandeha K, MartinezSosaa S, Wub J, et al. Trigeminal neuralgia: Comparison of characteristics and impact in patients with or without multiple sclerosis. Mult Scler Relat Disord 2019;34:41-6.
8. Ericsona H, Hamdeha SA, Freyhultb E, et al. Cerebro spinal fluid biomarkers of inflammation in trigeminal neuralgia patients operated with microvascular decompression. PAIN 2019;160:2603-11.
9. Goadsby P J, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks the rapies. Brain 1994;117:427-34.
10. Varım C, Acar BA, Uyanık MS, et al. Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome. Singapore Med J 2016;57:514-6.
11. Tak AZA, Sengul Y. Evaluation of Inflammation with Neutrophil-to-lymphocyte Ratio and Platelet-tolymphocyte Ratio in Restless Legs Syndrome. Turk J Neurol 2018;24:259-63.
12. Zhao QT, Zhang XP, Zhang H, et al. Prognostic role of platelet to lymphocyte ratio in esophageal cancer. Oncotarget 2017;20:112085-93.
13. Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyteratio (NLR) and platelet to lymphocyteratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 2016;26:372-6.
14. No authors listed. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211.
15. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240-4.
16. Matsuda M, Huh Y, Rong R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesthesia 2018;127:582-91.
17. Strittmatter M, Grauer M, Isenberg E, et al. Cerebrospinal Fluid Neuropeptides and Monoaminergic Transmitters in PatientsWith Trigeminal Neuralgia. Headache 1997;37:211-6.
18. Samsam M, Coveñas R, Csillik B, et al. Depletion of substance P, neurokinin A and calcitonin gene related peptide fromthe contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; a possible neurophysiological and neuroanatomical link to generalized headpain. J Chem Neuroanat 2001;21:161-9.
19. Tarsa L, Balkowiec-Iskra E, Kratochvil FJ, et al. Tooth pulp inflammation increases brain-derived neurotrophic factor expression in rodent trigeminal ganglion neurons. Neuroscience 2010;167:1205-15.
20. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to corticalpathology in multiple sclerosis. Brain 2011;134:2755-71.
21. Magliozzi R, Howell OW, Reeves C, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010;68:477-93.
22. Sindou M, Leston J, Decullier E, et al. Microvascular decompression for primary trigeminal neuralgia: longterm effectiveness And prognostic factors in a series of 362 consecutive patients with clear cut neurovascular conflicts who underwent puredecompression. J Neurosurg 2007;107:1144–53.
23. Liu Y, Li J, Butzkueven H, et al. Microstructural abnormalities in the trigeminal nerves of patients with trigeminal neuralgia revealed by multiple diffusion metrics. Eur J Radiol 2013;82:783-6.